<https://rdf.molmedb.upol.cz/reference/ref465> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM00469>;
	<http://purl.org/dc/terms/bibliographicCitation> "Boulton DW, DeVane CL, Liston HL, Markowitz JS.: In vitro P-glycoprotein affinity for atypical and conventional antipsychotics. Life Sci, Volume 71 (2), 2002"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM00499>,
		<https://identifiers.org/molmedb/MM00561>;
	<http://purl.org/ontology/bibo/doi> "10.1016/s0024-3205(02)01680-6"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM00461>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM00557>;
	<http://purl.org/ontology/bibo/pmid> "12031686"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/transporter/target35> .
<https://rdf.molmedb.upol.cz/transporter/tra31812> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref465> .
<https://rdf.molmedb.upol.cz/transporter/tra31789> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref465> .
<https://rdf.molmedb.upol.cz/transporter/tra32772> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref465> .
<https://rdf.molmedb.upol.cz/transporter/tra31858> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref465> .
<https://rdf.molmedb.upol.cz/transporter/tra31779> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref465> .
<https://rdf.molmedb.upol.cz/transporter/tra31846> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref465> .
